Live
- UP govt prepares question banks for students
- Educating youth about importance of maintaining a healthy liver
- Nine candidates enter the poll fray on first day
- IIT-K, BFI forge partnership to accelerate healthcare innovation
- Nurture self-confidence and growth
- Nominations filed for Kurnool & Nandyal constituencies
- YSRCP’s ‘poor’ candidate owns assets of Rs 161 crore
- 12 nominations filed on Day-1
- Infy profit zooms 30% to ₹ 7,969cr in Q4
- Only 9.83 pc candidates are women in NE states
Zydus Cadila gets DCGI nod to initiate Phase-3 trials
Zydus Cadila gets DCGI nod to initiate Phase-3 trials
Highlights
Drug firm Zydus Cadila on Sunday said it has received DCGI approval to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D
New Delhi: Drug firm Zydus Cadila on Sunday said it has received DCGI approval to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D.
The company will now be initiating Phase III clinical trial in around 30,000 volunteers, Zydus Cadila said in a statement. ZyCoV-D was found to be safe, well-tolerated and immunogenic in phase I and II clinical trials, it added.
Next Story
ADVERTISEMENT
